Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 3 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Adial Pharmaceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +7 vs. Q3 2025
- Shares held
- 3.54M
- +2.93M (+479.9%) vs. Q3 2025
- Total value
- $778.4K
- +$563.6K (+262.4%) vs. Q3 2025
- New holders
- 8
- 4 more added
- Sold out
- 1
- 4 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADIL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $334.6K |
| Q1 2026 | 15 | $63.8K |
| Q4 2025 | 24 | $778.4K |
| Q3 2025 | 17 | $214.8K |
| Q2 2025 | 17 | $70.8K |
| Q1 2025 | 14 | $152.7K |
| Q4 2024 | 15 | $298.1K |
| Q3 2024 | 12 | $195.9K |
| Q2 2024 | 16 | $328.0K |
| Q1 2024 | 16 | $236.2K |
| Q4 2023 | 17 | $495.3K |
| Q3 2023 | 11 | $164.2K |
| Q2 2023 | 21 | $488.2K |
| Q1 2023 | 23 | $876.9K |
| Q4 2022 | 23 | $359.2K |
| Q3 2022 | 28 | $692.1K |
| Q2 2022 | 26 | $2.27M |
| Q1 2022 | 23 | $6.38M |
| Q4 2021 | 24 | $3.61M |
| Q3 2021 | 21 | $5.50M |
| Q2 2021 | 19 | $3.15M |
| Q1 2021 | 20 | $1.95M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Adial Pharmaceuticals, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 1 | $0 | 0.00% | +1 | New |
| Morgan Stanley | 9 | $2 | 0.00% | 00.0% | Unchanged |
| Abound Wealth Management | 27 | $6 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 99 | $22 | 0.00% | +99 | New |
| Wells Fargo & Company | 160 | $35 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 205 | $45 | 0.00% | +23+12.6% | Added |
| SBI Securities Co., Ltd. | 1,158 | $255 | 0.00% | −238−17.0% | Reduced |
| Tower Research Capital LLC (TRC) | 1,341 | $295 | 0.00% | −29−2.1% | Reduced |
| Raffa Wealth Management, LLC | 2,093 | $460 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 9,167 | $2.02K | 0.00% | −9,591−51.1% | Reduced |
| Private Management Group Inc | 10,000 | $2.20K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 12,087 | $2.66K | 0.00% | +12,087 | New |
| Two Sigma Securities, LLC | 17,074 | $3.76K | 0.00% | +4,233+33.0% | Added |
| StoneX Group Inc. | 19,451 | $4.28K | 0.00% | +19,451 | New |
| BlackRock, Inc. | 27,770 | $6.11K | 0.00% | 00.0% | Unchanged |
| Manchester Capital Management LLC | 48,097 | $10.6K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 52,097 | $11.5K | 0.00% | +52,097 | New |
| Virtu Financial LLC | 63,827 | $14.0K | 0.00% | +63,827 | New |
| Northern Trust Corp | 65,979 | $14.5K | 0.00% | +65,979 | New |
| Jane Street Group, LLC | 121,841 | $26.8K | 0.00% | +109,500+887.3% | Added |
| Geode Capital Management, LLC | 155,745 | $34.3K | 0.00% | −8,382−5.1% | Reduced |
| Vanguard Group Inc | 156,024 | $34.3K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 219,621 | $48.3K | 0.00% | +75,830+52.7% | Added |
| Armistice Capital, LLC | 2,554,442 | $562.0K | 0.01% | +2,554,442 | New |
| HRT Financial LP | 0 | $0 | 0.00% | −11,191−100.0% | Sold out |